Origen sells healthcare arm to Towergate

Laura Miller
clock

Origen, the Aegon-owned IFA, has sold its healthcare business to Towergate Healthcare.

Six staff and Origen's book of private medical insurance business will transfer to Towergate Healthcare, which will provide future healthcare services to Origen clients. Other terms of the sale have not been disclosed. Origen says the sale was necessary because the "significant" level of research, analysis and resource required for it to service the growing healthcare needs of employers and requirements of clients "did not make sense". Stephen Greenstreet, managing director of Origen, says: "The longer term interests of our clients will be better served by establishing a strategic p...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Your profession

Polling high – should advisers bank on Reform UK holding on?

Polling high – should advisers bank on Reform UK holding on?

Nigel Farage-led party's policies would likely mean big tax changes if Reform came into power

Isabel Baxter
clock 30 July 2025 • 7 min read
Financial planning 'badly' needed PFS £1m talent pledge – what next?

Financial planning 'badly' needed PFS £1m talent pledge – what next?

Considerations include representation, showing not telling, and small business support

Jen Frost
clock 29 July 2025 • 6 min read
FNZ hit with $4.6bn class action from employee shareholders

FNZ hit with $4.6bn class action from employee shareholders

Claimants argue institutional investors received new shares and warrants on more favourable terms

Sahar Nazir
clock 28 July 2025 • 1 min read